162 related articles for article (PubMed ID: 31385521)
1. Blood circulating miRNAs as biomarkers of Alzheimer's disease: a systematic review and meta-analysis.
Zhang YH; Bai SF; Yan JQ
Biomark Med; 2019 Aug; 13(12):1045-1054. PubMed ID: 31385521
[No Abstract] [Full Text] [Related]
2. Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
Wu HZ; Ong KL; Seeher K; Armstrong NJ; Thalamuthu A; Brodaty H; Sachdev P; Mather K
J Alzheimers Dis; 2016; 49(3):755-66. PubMed ID: 26484928
[TBL] [Abstract][Full Text] [Related]
3. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
[TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNAs as Diagnostic Biomarkers of Clinical Cognitive Impairment: A Meta-Analysis.
Shi D; Han M; Liu W; Tao J; Chen L
Am J Alzheimers Dis Other Demen; 2020; 35():1533317520951686. PubMed ID: 33094634
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs as novel biomarkers of Alzheimer's disease.
Zendjabil M
Clin Chim Acta; 2018 Sep; 484():99-104. PubMed ID: 29800558
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
[TBL] [Abstract][Full Text] [Related]
7. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.
Geekiyanage H; Jicha GA; Nelson PT; Chan C
Exp Neurol; 2012 Jun; 235(2):491-6. PubMed ID: 22155483
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of cerebrospinal fluid Aβ(1-42) for Alzheimer's disease diagnosis: a systematic review and meta-analysis.
Rosa MI; Perucchi J; Medeiros LR; Fernandes B; Fernandes Dos Reis ME; Silva BR
J Alzheimers Dis; 2014; 40(2):443-54. PubMed ID: 24448789
[TBL] [Abstract][Full Text] [Related]
9. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of plasma amyloid-β levels in Alzheimer's disease.
Song F; Poljak A; Valenzuela M; Mayeux R; Smythe GA; Sachdev PS
J Alzheimers Dis; 2011; 26(2):365-75. PubMed ID: 21709378
[TBL] [Abstract][Full Text] [Related]
11. Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer's disease.
Chen JJ; Yang G; Yan QQ; Zhao J; Li S
Rev Neurosci; 2019 Dec; 31(1):77-87. PubMed ID: 31318699
[TBL] [Abstract][Full Text] [Related]
12. Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease.
Han Y; Jia J; Jia XF; Qin W; Wang S
Neurosci Lett; 2012 May; 516(2):232-6. PubMed ID: 22503901
[TBL] [Abstract][Full Text] [Related]
13. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
14. Circulating micro-RNAs Differentially Expressed in Korean Alzheimer's Patients With Brain Aβ Accumulation Activate Amyloidogenesis.
Mankhong S; Kim S; Moon S; Choi SH; Kwak HB; Park DH; Shah P; Lee PH; Yang SW; Kang JH
J Gerontol A Biol Sci Med Sci; 2023 Feb; 78(2):292-303. PubMed ID: 35532940
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
Goldknopf IL; Park HR; Sabbagh M
Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
[TBL] [Abstract][Full Text] [Related]
16. Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid.
Wiedrick JT; Phillips JI; Lusardi TA; McFarland TJ; Lind B; Sandau US; Harrington CA; Lapidus JA; Galasko DR; Quinn JF; Saugstad JA
J Alzheimers Dis; 2019; 67(3):875-891. PubMed ID: 30689565
[TBL] [Abstract][Full Text] [Related]
17. Circulating miR-125b as a biomarker of Alzheimer's disease.
Tan L; Yu JT; Liu QY; Tan MS; Zhang W; Hu N; Wang YL; Sun L; Jiang T; Tan L
J Neurol Sci; 2014 Jan; 336(1-2):52-6. PubMed ID: 24139697
[TBL] [Abstract][Full Text] [Related]
18. The potential diagnostic accuracy of circulating microRNAs for Alzheimer's disease: A meta-analysis.
Zhang WT; Zhang GX; Gao SS
Neurologia (Engl Ed); 2024 Mar; 39(2):147-159. PubMed ID: 38460993
[TBL] [Abstract][Full Text] [Related]
19. Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
Shobeiri P; Alilou S; Jaberinezhad M; Zare F; Karimi N; Maleki S; Teixeira AL; Perry G; Rezaei N
PLoS One; 2023; 18(3):e0281784. PubMed ID: 36947499
[TBL] [Abstract][Full Text] [Related]
20. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.
Shahpasand-Kroner H; Klafki HW; Bauer C; Schuchhardt J; Hüttenrauch M; Stazi M; Bouter C; Wirths O; Vogelgsang J; Wiltfang J
Alzheimers Res Ther; 2018 Dec; 10(1):121. PubMed ID: 30526652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
